Stellate Ganglion Blockade for Refractory Chronic Migraine | MicrobiomeTrials← Back to trialsNCT06891118
Stellate Ganglion Blockade for Refractory Chronic Migraine
CompletedNAINTERVENTIONAL
Trial Details
Start: 2024-03-06Est. Completion: 2025-12-30
Enrollment target: 42 participants Locations- Health Sciences University, Ankara Bilkent City Hospital, Ankara, Cankaya, Turkey (Türkiye)
Other microbiome trials you might be interested in
Chronic Migraine Headache
To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUI…
Bishkek, KyrgyzstanCompleted Apr 2028
MigraineMigraine Disorder
The goal of this clinical trial is to determine the effectiveness of Tai Chi training and acupuncture on the migraine at…
Hung Hom, Hong KongEst. completion Oct 31, 2026
Medication Overuse Headache
Electroacupuncture
Acupuncture is commonly used for the prevention of migraine and tension-type headaches, and has been found to be effecti…
Beijing, ChinaEst. completion Dec 2027